Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 90
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03385395 | Study Comparing Weekly Intravenous Administration of OctaAlpha1 With a Marketed Preparation Glassia® in Subjects With Alpha-1-antitrypsin Deficiency | ||
| NCT03348618 | A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) | ||
| NCT02267226 | Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery | ||
| NCT02503293 | A Study to Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL Administered With Two Different Delivery Devices: Injections Using Pump or Rapid Push | ||
| NCT03866798 | Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopenia (ITP) | ||
| NCT01992549 | Study to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII | ||
| NCT00411801 | Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP) | ||
| NCT07220915 | Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections | ||
| NCT03695978 | Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients | ||
| NCT01859754 | Octagam 5% Versus Comparator Post Marketing Trial | ||
| NCT01313507 | High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam) | ||
| NCT02303093 | Non-Interventional Study on the Tolerability and Efficacy of IVIG | ||
| NCT03369301 | The Effect of Subcutaneous Immunoglobulin Gammanorm on the Distribution of IgG Subclasses and on Immunity of Patients With Secondary Immunodeficiency | ||
| NCT00426270 | Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults | ||
| NCT04534751 | Factor In the Initial Resuscitation of Severe Trauma 2 Patients | ||
| NCT02278575 | Atenativ Effect on Uterine Blood Flow and Preeclampsia | ||
| NCT03907241 | CLINICAL PHASE III STUDY TO MONITOR THE SAFETY, TOLERABILITY AND EFFICACY OF SUBCUTANEOUS HUMAN IMMUNOGLOBULIN (OCTANORM) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES, INCLUDING (BUT NOT LIMITED TO) THOSE WHO HAVE COMPLETED THE SCGAM-01 TRIAL | ||
| NCT03369314 | Observational Study of the Use of octaplasLG®. | ||
| NCT04354129 | Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodeficiency. | ||
| NCT04640142 | Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases | ||
| NCT03677557 | Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment | ||
| NCT04106908 | Effectiveness and Tolerability of Eqwilate in Real-life Conditions | ||
| NCT00812565 | Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease | ||
| NCT04918173 | Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery | ||
| NCT03656640 | Trial Assessing Safety and Efficacy of Gammanorm® in Autoimmune Diseases | ||
| NCT03686969 | Study Evaluating Efficacy and Safety of Octanorm in Patients With Dermatomyositis | ||
| NCT04106895 | Use of Fibryga, a Fibrinogen Concentrate in Real World: Retrospective Collection of Clinical Data | ||
| NCT00811174 | Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency Diseases | ||
| NCT04400058 | Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression | ||
| NCT04146376 | Von Willebrand Factor in Pregnancy (VIP) Study | ||
| NCT01225276 | Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP | ||
| NCT02728752 | Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) | ||
| NCT06599697 | The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy | ||
| NCT05936580 | Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery | ||
| NCT01888484 | Study of Octanorm Subcutaneous IG in Patients With PID | ||
| NCT03793426 | Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency | ||
| NCT02972281 | Systematic Search for Primary Immunodeficiency in Adults With Infections | ||
| NCT01938404 | Octaplas Adult TTP Trial | ||
| NCT05935358 | Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study | ||
| NCT04052698 | Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD | ||
| NCT02256917 | Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A | ||
| NCT02638207 | Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) Neuropathy | ||
| NCT01012323 | A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases | ||
| NCT02115503 | A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft Recipients | ||
| NCT06096116 | Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass | ||
| NCT02740335 | Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk. | ||
| NCT04053699 | Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment | ||
| NCT02954575 | Clinical Study to Investigate the PK, Efficacy, and Safety of Wilate in Patients With Severe Hemophilia A | ||
| NCT04376762 | Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery Patients | ||
| NCT02037373 | Evaluation of the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation |
